4-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylic acid, 97%, 250mg

2-(4-methylphenyl)-1H-indene-1,3(2H)-dione, 95.0%, 1g

N-(4-Bromophenyl)butanamide, 95.0%, 5g

Fmoc-Lys(Dnp)-OH, 95%, 5g

4-Phenylpyrrolidin-3-amine dihydrochloride, 98%, 250mg

2-azidoethyl methanesulfonate, 1g

tert-Butyl 1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, 95.0%, 5g

Ipsapirone, 99.87%, 25mg

GLYCIDYL (R)-(-)-4-NITROBENZENESULFONATE, 97.0%, 1g

3-{[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}phenol, 500mg

Clemastine Fumarate>98.0%(HPLC)(T)250mg

4-bromo-2-fluoro-2'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

Plan PLi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm